Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!

Rare Diseases

Pharma News for Aktis, Alcon and Takeda

Notizia - Recent Pharma, Healthcare and Biotech Happenings

Aktis’s Novel Targeted Alpha Radiopharmaceuticals; Koye Partners with Sonde Health; Novartis to Spin Off Sandoz Business; Alcon to Buy Aerie Pharma; Fast Track Designation to Merck’s MK-2060; FDA Approves Ibrutinib for Chronic GvHD; French Authorities Clears BrainVectis’s Clinical Trial; Takeda’s Dengue Vaccine TAK-003 Gets Approval in Indonesia

Explore More...
Hypofibrinogenemia Market | Rare Bleeding Disorders

Hypofibrinogenemia Market: Limited Pipeline Therapies, Abundant Opportunities

Rare diseases challenges | Rare diseases clinical trials, incidence, and funding

The Paradox of Rare: Chalking out Challenges in the Rare Disease Market

Rare Diseases Incidence | Rare Disease Market | Synovial sarcoma | Argininosuccinic aciduria | Biliary atresia

Limited Therapies in the Rare Disease Pipeline: Watch out for Rare Indications that Calls Out for Novel Therapies

Hemophagocytic Lymphohistiocytosis Treatment Market

A Bleak Pipeline and Lack of Approved Treatment Clouds the Hemophagocytic Lymphohistiocytosis Market Size Growth

Biohaven's Troriluzole; Daiichi/ AZ's Enhertu; Fujifilm Manufacturing Units

Biohaven’s Troriluzole Failure; Daiichi/ AZ’s Enhertu; Fujifilm & Manufacturing Spree; J&J’s Darzalex Faspro

Angelman Syndrome Market Landscape and Late-stage Clinical Failures

Angelman Syndrome Market: Insights Into The Recent Late-Stage Drug Failures And Novel Approaches To Treating This Rare Neurogenetic Disorder

Pfizer’s Somatrogon; SCONE device; ATG-010; SanBio in Neurology

Pfizer/ OPKO Health’s Somatrogon; FDA EU for SCONE device; Antengene ATG-010 for rrMM and rrDLBCL; SanBio STEMTRA Phase 2 Interim Results

Amyotrophic Lateral Sclerosis Pipeline

Top 10 Most Promising Drugs In The Amyotrophic Lateral Sclerosis Treatment Landscape

8-Most-Common-Foods-Allergies-and-their-signs-symptoms-causes-risk-factors-treatment-options-epidemiology

8 Of The Most Common Foods Allergies – Do You Have One?

Frequently Asked Questions About Epilepsy And Seizures

21 of the most common questions about Epilepsy

KaliVir, Astellas deal; AbCellera IPO; Bayer's CAR-T collabs; NASH therapy

KaliVir, Astellas licensing deal; AbCellera’s IPO; Bayer CAR-T Cell therapy collab with Atara; Aligos, Merck together against NASH

Epilepsy Market

Ever-evolving Market Dynamics of Epilepsy – a silver lining!

C3G Market | Complement 3 Glomerulopathy Market

Key Pharma Players Transforming the Complement 3 Glomerulopathy Market Landscape

Argininosuccinic aciduria Treatment Market

Argininosuccinic Aciduria Market Awaits Innovative Treatment Expected To Launch In The Next Decade

Epidermolysis-Bullosa-Market-size-share-trends-growth-forecast

Pharma Players Line Up To Launch Novel Therapies Fueling Epidermolysis Bullosa Market Size

pharma-news-for-roche-prestige-covid-19

Venclexta full approval; PBP1510 Orphan Status; Roche/ Genesis collab; Immunomodulators for COVID-19

Subscribe to our Updates

DelveInsight is dedicated to safeguarding your data. We ensure that your information is handled in compliance with relevant data privacy legislation, our internal guidelines, and our privacy policy.

Receive recent Healthcare updates directly in your inbox.

Days
loader